We are live on
!
Find out more
Vanguard Group Portfolio holdings
AUM
$6.9T
1-Year Est. Return
27.45%
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
This Fund
S&P 500
This Quarter
Est. Return
+14.09%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$6.18T
AUM Growth
+$647B
(+12%)
Cap. Flow
+$78.1B
Cap. Flow
% of AUM
1.26%
Top 10 Holdings %
Top 10 Hldgs %
28.81%
Holding
4,383
New
103
Increased
2,425
Reduced
1,410
Closed
108
Avg Time Held
32.4
quarters
Top 10 Avg Time Held
19.2
quarters
Top 20 Avg Time Held
24.2
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$5.95B |
| 2 |
NVIDIA
NVDA
|
+$4.97B |
| 3 |
Capital One
COF
|
+$4.5B |
| 4 |
Amazon
AMZN
|
+$3.45B |
| 5 |
Flutter Entertainment
FLUT
|
+$3.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Discover Financial Services
DFS
|
+$5.32B |
| 2 |
Intra-Cellular Therapies Inc.
ITCI
|
+$1.26B |
| 3 |
Amphenol
APH
|
+$1.18B |
| 4 |
Welltower
WELL
|
+$987M |
| 5 |
US Steel
X
|
+$825M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.14% |
| 2 | Financials | 14% |
| 3 | Consumer Discretionary | 10.14% |
| 4 | Healthcare | 9.38% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3951
Minerva Neurosciences
NERV
$152M
| $434K | ﹤0.01% |
252,060
| – | – |
2015 Q1
41 quarters
|
|
3952
Datavault AI
DVLT
$133M
| $433K | ﹤0.01% |
653,833
-609,320
| -48% | -$472K |
2024 Q3
3 quarters
|
|
3953
Retractable Technologies
RVP
$19.9M
| $431K | ﹤0.01% |
673,809
-15,700
| -2% | -$10.9K |
2013 Q2
48 quarters
|
|
3954
Local Bounti
LOCL
$24.8M
| $431K | ﹤0.01% |
184,141
| – | – |
2021 Q4
14 quarters
|
|
3955
Collective Mining Ltd
CNL
$1.12B
| $427K | ﹤0.01% |
+39,010
| New | +$396K |
2025 Q2
0 quarters
|
|
3956
OneMedNet
ONMD
$25M
| $426K | ﹤0.01% |
74,750
| – | – |
2024 Q2
4 quarters
|
|
|
MGIC
3957
DELISTED
Magic Software Enterprises
MGIC
| $426K | ﹤0.01% |
22,261
-10,630
| -32% | -$160K |
2020 Q4
18 quarters
|
|
3958
JD.com
JD
$36.6B
| $424K | ﹤0.01% |
+12,994
| New | +$443K |
2025 Q2
0 quarters
|
|
3959
Marker Therapeutics
MRKR
$16.2M
| $421K | ﹤0.01% |
275,345
| – | – |
2017 Q3
31 quarters
|
|
3960
Xos
XOS
$45.6M
| $420K | ﹤0.01% |
139,156
| – | – |
2021 Q3
15 quarters
|
|
3961
CEL-SCI Corp
CVM
$34.1M
| $420K | ﹤0.01% |
183,211
+104,775
| +134% | +$549K |
2013 Q2
48 quarters
|
|
3962
Tigo Energy
TYGO
$68.3M
| $416K | ﹤0.01% |
326,524
+42,735
| +15% | +$41.6K |
2023 Q3
7 quarters
|
|
3963
Vanguard Energy ETF
VDE
$11B
| $412K | ﹤0.01% |
3,459
+16
| +0.5% | +$1.86K |
2023 Q1
9 quarters
|
|
3964
Rani Therapeutics
RANI
$92.2M
| $411K | ﹤0.01% |
799,679
| – | – |
2021 Q3
15 quarters
|
|
3965
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$57.8B
| $411K | ﹤0.01% |
4,307
+198
| +5% | +$17K |
2024 Q2
4 quarters
|
|
3966
ASML
ASML
$684B
| $408K | ﹤0.01% |
+509
| New | +$365K |
2025 Q2
0 quarters
|
|
3967
Cognition Therapeutics
CGTX
$83.4M
| $404K | ﹤0.01% |
1,304,350
+65,183
| +5% | +$22K |
2021 Q4
14 quarters
|
|
3968
Jewett-Cameron Trading
JCTC
$10.2M
| $403K | ﹤0.01% |
106,937
| – | – |
2013 Q2
48 quarters
|
|
3969
Q32 Bio
QTTB
$248M
| $401K | ﹤0.01% |
269,429
-39,785
| -13% | -$67.8K |
2018 Q1
29 quarters
|
|
3970
NextCure
NXTC
$32.9M
| $401K | ﹤0.01% |
72,668
-9,609
| -12% | -$51.6K |
2019 Q2
24 quarters
|
|
3971
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.4B
| $401K | ﹤0.01% |
7,656
+654
| +9% | +$32.7K |
2024 Q3
3 quarters
|
|
3972
Cellectar Biosciences
CLRB
$13.7M
| $401K | ﹤0.01% |
56,341
-1,054
| -2% | -$9.22K |
2016 Q2
36 quarters
|
|
3973
Cocrystal Pharma
COCP
$20.6M
| $399K | ﹤0.01% |
268,080
-7,576
| -3% | -$11.3K |
2018 Q2
28 quarters
|
|
3974
Datacentrex Inc
DTCX
$67M
| $396K | ﹤0.01% |
56,503
+31,968
| +130% | +$205K |
2025 Q1
1 quarter
|
|
3975
Barnwell Industries
BRN
$14.1M
| $394K | ﹤0.01% |
348,814
| – | – |
2013 Q2
48 quarters
|
|
Similar funds
CWM
FAF
BGIM
CIM
UOC
Vanguard Group's Q2 2025 Portfolio in Review
As of Q2 2025, Vanguard Group held 4,383 positions worth $6.18T, up 12% from $5.53T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Trading was light in Q2 2025: portfolio turnover was 4.8%. Vanguard Group opened 103 new positions and exited 108, leaving the 4,383-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Consumer Discretionary.
- Vanguard Group's largest Q2 2025 buy was Amrize Ltd: 21,350,540 shares worth $1.07B.
- Vanguard Group added most to Microsoft in Q2 2025, an estimated $5.95B increase.
- Vanguard Group's biggest Q2 2025 reduction was Amphenol, cutting an estimated $1.18B.
- Vanguard Group fully exited Discover Financial Services in Q2 2025, selling an estimated $5.32B.
- Vanguard Group's ten largest holdings make up 29% of its $6.18T portfolio in Q2 2025.
- Vanguard Group opened 103 new positions and closed 108 in Q2 2025.
- Vanguard Group's portfolio value rose 12% quarter-over-quarter to $6.18T.
Based on Vanguard Group's 13F filing for Q2 2025, filed 11 Aug 2025.